Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Curis Inc., 3 years.
Curis Inc.
Director
NextCure Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 1, 2025 | Sutro Biopharma Inc. | Option exercise | +53,125 | — | — |
| May 1, 2025 | Sutro Biopharma Inc. | Option exercise | +15,938 | — | — |
| May 1, 2025 | Sutro Biopharma Inc. | Shares withheld for tax | −24,709 | $1.07 | $26,439 |
| Mar 1, 2025 | Sutro Biopharma Inc. | Option exercise | +11,250 | — | — |
| Mar 1, 2025 | Sutro Biopharma Inc. | Shares withheld for tax | −4,621 | $1.59 | $7,347 |
| Feb 28, 2025 | Sutro Biopharma Inc. | Option exercise | +37,500 | — | — |
| Feb 28, 2025 | Sutro Biopharma Inc. | Shares withheld for tax | −15,405 | $1.59 | $24,494 |
| Feb 29, 2024 | Sutro Biopharma Inc. | Option exercise | +37,500 | — | — |
| Feb 29, 2024 | Sutro Biopharma Inc. | Shares withheld for tax | −13,126 | $4.91 | $64,449 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.